M2 macrophages treatment inhibits the levels of inflammatory
cytokines in serum
When compared to the control group, a significant reduction in the
expressions of inflammatory cytokines including IL-1β, IL-17A, TNF-α and
IL-6 were observed in the M2 macrophages treatment group (p﹤0.05). By
contrast, the levels of the anti-inflammatory cytokines IL-4 and IL-10
in M2 macrophages treatment group tended to rise. However, there was no
significant difference regarding the expression of IL-4, IL-10 and IL-12
between the control and M2 treatment groups (Figure 2f).